EPS Bio Technology

EPS Bio Technology Diluted EPS

The Diluted Earnings per Share of EPS Bio Technology (4183.TWO) as of Nov 5, 2026 is -0.33 TWD. In the previous year, Diluted Earnings per Share was 0.73 TWD — a change of -145.45% (lower).

Diluted EPS

-0.33TWD

YoY

-145.45%

Last updated:

Diluted Earnings per Share of EPS Bio Technology is 2025 -0.33 TWD. Diluted Earnings per Share of EPS Bio Technology was 2024 0.73 TWD. It decreases by -145.45% lower compared to the previous year.

The EPS Bio Technology Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
0.66 TWD
Jan 1, 2019
0.77 TWD
Jan 1, 2020
1.33 TWD
Jan 1, 2021
0.78 TWD
Jan 1, 2022
1.07 TWD
Jan 1, 2023
0.88 TWD
Jan 1, 2024
0.73 TWD
Jan 1, 2025
-0.33 TWD
The EPS Bio Technology Diluted EPS history
YEARDiluted EPSYoY
-0.33TWD-145.45%
0.73TWD-17.31%
0.88TWD-17.66%
1.07TWD+36.38%
0.78TWD-41.20%
1.33TWD+71.93%
0.77TWD+17.09%
0.66TWD+450.00%
0.12TWD-91.37%
1.39TWD-21.47%
1.77TWD-212.03%
-1.58TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EPS Bio Technology Stock analysis

What does EPS Bio Technology do? EPS Bio Technology Corp, listed on the Taiwan Stock Exchange with ticker 4183.TWO and ISIN TW0004183009, is headquartered in Baoshan, Taiwan. The company operates within the Health Care sector, specifically in the Health Care industry. It has a workforce of 123 employees. EPS Bio Technology Corp completed its initial public offering (IPO) on November 13, 2012. The company's primary business activities involve the development and manufacture of blood glucose monitoring systems, as well as the development and sales of various medical and related medical equipment. Its main product lines include blood glucose testers, blood glucose test strips, and electric breast pumps. The firm primarily distributes its products to international markets, with a focus on Europe, North America, and other regions in Asia. The company's official website is http://www.epsbio.com.tw/. EPS Bio Technology Corp does not disclose specific financial figures or additional details about its operations beyond the provided information. The company is based in Baoshan, Hsinchu, though the source description mentions Hsinchu as the headquarters location, which is consistent with the city provided in the data. The company's operations are centered around medical technology, with an emphasis on diagnostic and consumer health products. EPS Bio Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EPS Bio Technology stock

Diluted Earnings per Share of EPS Bio Technology is -0.33 TWD in 2025.

Diluted Earnings per Share of EPS Bio Technology changed from 0.73 TWD to -0.33 TWD, representing a -145.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share EPS Bio Technology since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — EPS Bio Technology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — EPS Bio Technology